Reviva Pharmaceuticals Hldg Inc (RVPH)

$0.39 +0.04 (10.76%)
Market Cap 4.51M
Revenue (ttm) 0.00
Net Income (ttm) -19.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 742,000
Avg Vol 960,685
Day's Range N/A - N/A
Shares Out 12.81M
Stochastic %K 20%
Beta 0.75
Analysts Strong Sell
Price Target $12.67

Company Profile

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity di...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 501 8881
Fax: 408 904 6270
Address:
10080 N. Wolfe Road, Suite SW3-200, Cupertino, United States
Anomalies
Anomalies May. 30 at 6:40 PM
$RVPH
0 · Reply
GI197845
GI197845 May. 30 at 4:19 AM
$RVPH We are through the looking-glass here folks, buy all you can,hand over fist and back the truck up, load up all you can!!! To da' moon baby!
0 · Reply
GI197845
GI197845 May. 30 at 4:16 AM
$RVPH Best stock in the world, we love Bhat Lax!
0 · Reply
DonkeyPuncherDude
DonkeyPuncherDude May. 28 at 5:18 PM
$RVPH BK BK B fuggin K
1 · Reply
Newcar
Newcar May. 28 at 5:16 PM
$RVPH No cash no party. Bankruptcy coming...
1 · Reply
Tron_G
Tron_G May. 27 at 4:28 PM
$RVPH wha happen
0 · Reply
ZacksSCR
ZacksSCR May. 27 at 2:22 PM
$RVPH First Quarter 2026 Results https://buff.ly/kRcDKBX
0 · Reply
biovaluable
biovaluable May. 27 at 8:08 AM
$UNCY indian stock....like $RVPH
1 · Reply
History101
History101 May. 27 at 1:20 AM
$RVPH i think Lax did this on purpose, to drive the stock price down to make it cheaper to take private.
0 · Reply
GI197845
GI197845 May. 21 at 7:32 PM
$RVPH Wow! We are on an upward trend!!! Lax Bhat rocks!!!
2 · Reply
Latest News on RVPH
No data available.
Anomalies
Anomalies May. 30 at 6:40 PM
$RVPH
0 · Reply
GI197845
GI197845 May. 30 at 4:19 AM
$RVPH We are through the looking-glass here folks, buy all you can,hand over fist and back the truck up, load up all you can!!! To da' moon baby!
0 · Reply
GI197845
GI197845 May. 30 at 4:16 AM
$RVPH Best stock in the world, we love Bhat Lax!
0 · Reply
DonkeyPuncherDude
DonkeyPuncherDude May. 28 at 5:18 PM
$RVPH BK BK B fuggin K
1 · Reply
Newcar
Newcar May. 28 at 5:16 PM
$RVPH No cash no party. Bankruptcy coming...
1 · Reply
Tron_G
Tron_G May. 27 at 4:28 PM
$RVPH wha happen
0 · Reply
ZacksSCR
ZacksSCR May. 27 at 2:22 PM
$RVPH First Quarter 2026 Results https://buff.ly/kRcDKBX
0 · Reply
biovaluable
biovaluable May. 27 at 8:08 AM
$UNCY indian stock....like $RVPH
1 · Reply
History101
History101 May. 27 at 1:20 AM
$RVPH i think Lax did this on purpose, to drive the stock price down to make it cheaper to take private.
0 · Reply
GI197845
GI197845 May. 21 at 7:32 PM
$RVPH Wow! We are on an upward trend!!! Lax Bhat rocks!!!
2 · Reply
DistributionEquity
DistributionEquity May. 21 at 7:01 PM
$RVPH The comparison to Caplyta was mentioned recently in several presentations......here is why. Long, strong and Brilaxin on!
1 · Reply
Stocks2Retire
Stocks2Retire May. 21 at 11:21 AM
$RVPH this will not get rerated unless a partner announcement or sale happens or some funds raised thru any non dilutive methods. everyone already knows asset value .. but in hands of bhat and co it will always be valued close to zero as today. Even some fda milestones of starting phase 3 etc wont help share price. They may be trying everything to take it private at near zero price. There are many examples of that in biotech.
1 · Reply
Stocks2Retire
Stocks2Retire May. 21 at 12:36 AM
$RVPH while NERV is gaining even with less effective drug Bhat and co will keep this asset private for treatment of their own personal conditions 🙁
0 · Reply
DistributionEquity
DistributionEquity May. 20 at 3:04 AM
$RVPH Next step is the very short / small bioequivalance study for the FDA - Once proven, the FDA greenlights the use of it in the second P3. That'll be the first major catalyst and (hopeful) rerating of the stock; Then enrollment > Sometime during the process, I'd expect to see a partnership announcement; A novel p3 CNS compound with potentially a 15+ year patent is a very attractive asset. Its gonna be a VERY interesting 12 months.
0 · Reply
rocket_buddy
rocket_buddy May. 19 at 5:45 PM
$RVPH https://finance.yahoo.com/sectors/healthcare/articles/reviva-participate-fireside-chat-g-120000847.html
1 · Reply
GI197845
GI197845 May. 19 at 4:11 AM
$RVPH Back up the truck and load up, now! now! now! To da moon, baby!!!
0 · Reply
GI197845
GI197845 May. 19 at 4:08 AM
$RVPH When is the reverse split coming? We need to get this Nasdaq compliant, so it can fly! That is the only thing holding this down from flying!!! We need that reverse split now!!!
1 · Reply
channelsurfer
channelsurfer May. 18 at 7:21 PM
$RVPH hey @Stocktwits & @StocktwitsIndia can you fix this broken ticker? Thanks 🙏
1 · Reply
hunter33
hunter33 May. 18 at 6:49 PM
$RVPH wow absolute garbage. still dumping
0 · Reply
shepsale
shepsale May. 18 at 3:01 PM
$RVPH Why it dosen't update to the OTC Market ?
0 · Reply
biovaluable
biovaluable May. 17 at 11:55 PM
$RVPH 인도짱개 주식을 아직도 들고 있는 반병신들은 뭐냐
2 · Reply
Anomalies
Anomalies May. 15 at 7:21 PM
$RVPH
0 · Reply